Home > Financial Ratios > THEMIS MEDICARE

THEMIS MEDICARE
Core EBITDA Growth

    Back to All Ratios
THEMIS MEDICARE is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

THEMIS MEDICARE Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -4.52-28.74-22.7392.3735.77

What is the latest Core EBITDA Growth ratio of THEMIS MEDICARE ?

The latest Core EBITDA Growth ratio of THEMIS MEDICARE is -4.52 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025-4.52
Mar2024-28.74
Mar2023-22.73
Mar202292.37
Mar202135.77

How is Core EBITDA Growth of THEMIS MEDICARE Trending?

Years Core EBITDA Growth % Change
Mar2025 -4.52
Negative
Mar2024 -28.74
Negative
Mar2023 -22.73
Negative
Mar2022 92.37
158.23
Mar2021 35.77 -

Other Financial Ratios of THEMIS MEDICARE


Compare Core EBITDA Growth ratio of peers of THEMIS MEDICARE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
THEMIS MEDICARE ₹727.6 Cr 5.1% -8.5% -50.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,603.0 Cr -5.6% -2.5% -1.7% Stock Analytics
DIVIS LABORATORIES ₹155,485.0 Cr -2.6% -8.7% 1.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,009.0 Cr -7.2% -8% 27.6% Stock Analytics
DR REDDYS LABORATORIES ₹101,628.0 Cr -6.5% -5.4% 3.9% Stock Analytics
CIPLA ₹96,400.8 Cr -4.1% -11.5% -19% Stock Analytics


THEMIS MEDICARE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
THEMIS MEDICARE

5.1%

-8.5%

-50.4%

SENSEX

-1%

-10.9%

-6%


You may also like the below Video Courses